1-3 of 3
Rafael Franco, MD
Close
Sort by
Journal Articles

Long Term Outcomes of ERT in Children with Gaucher Disease. Spanish Experience

Marcio M Andrade, MD, Pilar Alfonso, PhD, Pilar Irún, PhD, Javier Dalmau, MD, Jose Luis Barbera, MD, Horacio Cano, MD, María Angeles Fernandez-Galan, MD, Rafael Franco, MD, Inmaculada Garcia, MD, Angela Ibañez, MD, Francisco Lendinez, MD, Elena Martin-Hernandez, MD, Luis Antonio Sancho-Val, MD, Pablo Sanjurjo, MDPhD, Miguel Pocovi, Prof, Pilar Giraldo, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4950.
https://doi.org/10.1182/blood.V124.21.4950.4950
Published: 2014
Journal Articles

Substrate Reduction Therapy With Miglustat In Type 1 Gaucher Disease In Spain. Nine Years Outcomes Update On ZAGAL Study

Pilar Giraldo, MD PhD, Marcio M Andrade, Sr., MD, Blanca Medrano, Pilar Alfonso, PhD, Pilar Irún, PhD, Koldo Atutxa, MD, Angeles Fernandez-Galan, MD, Abelardo Barez, MD, Rafael Franco, MD, Inmaculada Roig, Vicente Giner, MD, Lucia Villalon, MD, Elisa Martinez-Estefano, MD, Elisa Luño, MD, Ines Loyola, MD, Olga Salamero, Javier de la Serna, MD, PhD, Miguel Pocovi
Journal: Blood
Blood (2013) 122 (21): 4713.
https://doi.org/10.1182/blood.V122.21.4713.4713
Published: 2013
Journal Articles

Short-Term Effect of Oral Treatment with Miglustat in Type 1 Gaucher Disease.

Pilar Giraldo, MD, PhD, Dora Alonso, MDPhD, M. Acedo, MD, Rafael Franco, MD, Alberto Barez, MD, Alejandro Corrales, MDPhD, D. Serrano, MD, Vanessa Roldan, MD, Paz Latre, MD, Pilar Alfonso, MDPhD, Miguel Pocovi, MDPhD
Journal: Blood
Blood (2005) 106 (11): 2235.
https://doi.org/10.1182/blood.V106.11.2235.2235
Published: 2005